Is MASH up or down today?
MASH is up 1.19% today, last at 338.66. This stock moved +1.19% versus the prior close.
MASH · MASH
MASH (MASH) is trading at 338.66, up 1.19% on the session. MASH sits at the 50% mark of its 52-week range, carries a 14-day RSI of 48, and trades below its 50-day average. Over the past month it is down 0.82%.
Leading the coverage: “Madrigal Pharmaceuticals (MDGL) Holds Ground Near $514 as MASH Franchise Gains Traction - Key Reversal Day - vinanet.vn” (Google News Company, 30d ago). MASH is -2.99% since story.
MASH trades on a trailing P/E of 39.0 and is running 0.12% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
MASH is up 1.19% today, last at 338.66. This stock moved +1.19% versus the prior close.
Leading the coverage: “Madrigal Pharmaceuticals (MDGL) Holds Ground Near $514 as MASH Franchise Gains Traction - Key Reversal Day - vinanet.vn” (Google News Company, 30d ago). MASH is -2.99% since story. Dominant story: Madrigal Doubles Down On MASH With A $4.4 Billion Licensing Deal With China’s Ribo - stocktwits.com (1 source, neutral) RSI is 48 — neutral Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (181 days) · Drag or scroll left for earlier dates
Madrigal Doubles Down On MASH With A $4.4 Billion Licensing Deal With China’s Ribo - stocktwits.com
Madrigal Pharmaceuticals (MDGL) Holds Ground Near $514 as MASH Franchise Gains Traction - Key Reversal Day - vinanet.vn
Inventiva: MASH Is Becoming A Combination Market Before Lanifibranor Arrives (NASDAQ:IVA) - Seeking Alpha
MDGL Stock Down Despite Q2 Beat, MASH Drug Drives Top-Line Y/Y Growth - Yahoo Finance
Madrigal Begins Phase 1 Trial of Oral GLP-1 Drug for MASH - Stock Titan